Disruptive Innovation in R&D Processes

Share:

Listens: 0

PharmaVOICE Podcasts

Science


In this episode, Dr. Davis discusses open innovation, nontraditional partnerships, collaboration, new technologies, and the future of R&D.Thought Leader: Dr. Hugh Davis, VP and head of Biologics Clinical Pharmacology Biotechnology Center of Excellence, Janssen Research and DevelopmentPlay podcast